Skip to main content
. 2021 Feb 4;7(2):365–378. doi: 10.1021/acscentsci.0c01670

Figure 10.

Figure 10

Antibody conjugation to the side chain of mutant PA is critical for enabling anthrax-based immunotoxins. (A) Design of previous retargeted-PA variants, in which a receptor-binding protein is either fused or conjugated to the C terminus of mPA. (B) Design of antibody-directed PA variants, in which an antibody is conjugated to a side chain of mPAC. (C, D) Design of antibody-directed PA variants, in which an antibody is fused to PA at either the N or C terminus of mPA.